SUMMARY Between 1978 and 1987, 439 patients with primary cervical carcinoma were
admitted to our department. Seventy-seven patients (17.5%) had cervical adenocarcinoma …

Serum levels of carcinoembryonic antigen (CEA) and cancer antigens CA 125 and CA 19.9
were determined by immunoradiometric assay in 96 patients diagnosed of invasive …

The prognostic value of the pretreatment serum CA 125, squamous cell carcinoma antigen
(SCC), and carcinoembryonic antigen (CEA) levels in relation to tumor type, vascular …

In the present study we evaluated the clinical usefulness of the tumor antigens, squamous
cell carcinoma antigen (SCC) and ovarian carcinoma antigen (CA 125), in populations of …

Serum levels of squamous cell carcinoma antigen SCC, carcinoembryonic antigen CA 125,
and tissue polypeptide antigen were determined in 142 patients with primary cervical …

A review is given of the clinical use and interpretation of serum tumor marker levels during
the treatment of patients with cancer of the uterine cervix. Pretreatment serum squamous cell …

Serum levels of CA-125 and squamous cell carcinoma-associated antigen (SCC) were
measured in 30 patients with squamous cell carcinoma and 12 patients with …

Tumor markers CA 125, carcinoembryonic antigen (CEA) and tumor-associated trypsin
inhibitor (TATI) were studied in 42 patients with cervical adenocarcinoma. Pretreatment …

A longitudinal study of circulating immune complexes (CIC), cancer antigen 125 (CA125),
carcinoembryonic antigen (CEA) and a sub-fraction of the TA-4 squamous cell carcinoma …

Immunohistochemical reactivities with CA 125, carcinoembryonic antigen (CEA), and CA 19‐
9 were studied in 15 cervixes without histologic abnormalities, ten with microglandular …